Market Closed -
Other stock markets
|
After market 11:58:16 am | |||
3.68 EUR | -2.90% | 3.683 | +0.08% |
May. 22 | CLARIANE : Primed to escape the sectoral ESG mud (con’t) | |
May. 22 | Clariane: opening of a clinic in Salon-de-Provence | CF |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+53.08% | 439M | B+ | ||
+17.74% | 83.47B | C+ | ||
-29.66% | 69.72B | B- | ||
-0.49% | 26.22B | C+ | ||
+4.03% | 17.69B | A- | ||
-12.16% | 16.83B | B | ||
+2.47% | 15.7B | A- | ||
+74.82% | 13.45B | C- | ||
+73.52% | 12.81B | C+ | ||
-0.87% | 12.69B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLARI Stock
- Ratings Clariane SE